➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Baxter

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Acetaminophen, and when can generic versions of Hydrocodone Bitartrate And Acetaminophen launch?

Hydrocodone Bitartrate And Acetaminophen is a drug marketed by Mallinckrodt, Mikart, Anda Repository, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Vintage Pharms, Vistapharm, Wes Pharma Inc, Abhai Llc, Able, Actavis Labs Fl Inc, Alvogen Pine Brook, Amneal Pharms, Amneal Pharms Ny, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Cerovene Inc, Epic Pharma Llc, Granules Pharms, Halsey, Ivax Pharms, Lannett Co Inc, Mutual Pharm, Nostrum Labs Inc, Novel Labs Inc, Par Pharm, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Tris Pharma Inc, Ucb Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, and Watson Labs Florida. and is included in one hundred and twenty-four NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND ACETAMINOPHEN is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Drug patent expirations by year for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Recent Clinical Trials for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sun Pharma Advanced Research Company LimitedPhase 1
Grünenthal GmbHPhase 1
INC ResearchPhase 3

See all HYDROCODONE BITARTRATE AND ACETAMINOPHEN clinical trials

Pharmacology for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.